Yeasen Biotechnology

Yeasen Biotechnology (Shanghai) Co., Ltd. is a leading biotechnology company founded in 2014, specializing in the development and production of high-quality enzymes, antibodies, and related reagents for the life sciences industry. Leveraging advanced technologies in protein engineering and directed evolution, Yeasen has become a key player in the fields of molecular biology, diagnostics, and biopharmaceuticals.

🔬 Core Technologies & Platforms

Yeasen has built six innovative core technology platforms that drive its research and product development:

• ZymeEditor™: A platform for protein directed evolution and rational design
• High-Density Fermentation & Ultra-Clean Purification: Enables large-scale, high-purity protein production
• HiSpecif™: Focused on the development of highly specific antibodies
• NGS Library Preparation R&D: Solutions for next-generation sequencing workflows
• Molecular Diagnostic Reagent R&D: Development of reagents for molecular diagnostics
• mRNA Vaccine & Drug R&D: Supports mRNA-based vaccine and therapeutic development

📦 Product Portfolio

Yeasen offers a comprehensive range of products, including:

• Molecular Biology Reagents: PCR and qPCR master mixes, reverse transcription kits, cloning kits, nucleic acid extraction and purification kits, in vitro transcription reagents
• NGS Library Preparation Kits: High-performance kits for NGS applications
• Cell Culture & Analysis Tools: Reagents for cell culture, transfection, and apoptosis detection
• Biopharmaceutical Reagents: GMP-grade enzymes and reagents for biopharma use
• Antibodies & Recombinant Proteins: Highly specific products for research and diagnostics

🧪 Custom Services

Yeasen also provides three main types of custom services:

• Molecular IVD Reagent Development (RDC)
• ZymeEditor™ Enzyme Engineering Platform
• CleaScrip™ Custom mRNA Synthesis